Analysis of the effect of crossover from placebo (PBO) to darolutamide (DARO) on overall survival (OS) benefit in the ARAMIS Trial. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Shore, Neal D
  • Fizazi, Karim
  • Tammela, Teuvo
  • Luz, Murilo
  • Philco Salas, Manuel
  • Ouellette, Paul
  • Lago, Sergio
  • Bastos, Diogo Assed
  • Jansz, Godfrey
  • Carcano, Flavio Mavignier
  • Andrade, Livia
  • Pliskin, Marc
  • Lazaretti, Nicolas
  • De Arruda, Larissa
  • Correa, Jose Jaime
  • Petrenciuc, Oana
  • Kappeler, Christian
  • Sarapohja, Toni
  • Smith, Matthew Raymond

publication date

  • February 20, 2021